Offer - Urjas Oil for just ₹ 1 X
Semi Reclimet Tablet (10) is a prescription medicine that is available as a Tablet. Diabetes are some of its major therapeutic uses. Semi Reclimet Tablet (10) also has some secondary and off-label uses. These are listed below.
The optimal dosage of Semi Reclimet Tablet (10) is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
Common side effects of Semi Reclimet Tablet (10) include Nausea or vomiting, Bradycardia, Constipation. While these are the most often observed Semi Reclimet Tablet (10) side effects, there are can be others also. These have been listed below. Such side effects of Semi Reclimet Tablet (10) normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Semi Reclimet Tablet (10) has a Moderate effect for pregnant women and Safe effect on lactating mothers. Warnings related to Semi Reclimet Tablet (10)'s effects on the liver, heart and kidney, if any, have been listed below.
The section on Semi Reclimet Tablet (10) contraindications lists all such conditions.
Drug reaction of Semi Reclimet Tablet (10) with other medicines has been reported. See below for a complete list.
You should also be aware that Semi Reclimet Tablet (10) is safe while driving, and is addiction.
Semi Reclimet Tablet (10) is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Semi Reclimet Tablet (10) safe for pregnant women?
Reclimet can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Reclimet right away. Take your doctor's advice before taking it again.
Is the use of Semi Reclimet Tablet (10) safe during breastfeeding?
Reclimet is completely safe for breastfeeding women.
What is the effect of Semi Reclimet Tablet (10) on the Kidneys?
Reclimet can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Semi Reclimet Tablet (10) on the Liver?
Reclimet may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Semi Reclimet Tablet (10) on the Heart?
There may be severe side effects of Reclimet on your heart. Do not take it unless a doctor says so.
If you are suffering from any of the following diseases, you should not take Semi Reclimet Tablet (10) unless your doctor advises you to do so -
Is this Semi Reclimet Tablet (10) habit forming or addictive?
Semi Reclimet Tablet (10) is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Yes, it is safe to do these activities or work after taking Semi Reclimet Tablet (10) as it does not make you drowsy.
Is it safe?
Yes, but consume Semi Reclimet Tablet (10) only on doctor's advice.
Is it able to treat mental disorders?
Semi Reclimet Tablet (10) is unable to treat or cure mental disorders.
Interaction between Food and Semi Reclimet Tablet (10)
Taking Semi Reclimet Tablet (10) with food does not harm your health.
Interaction between Alcohol and Semi Reclimet Tablet (10)
Consuming Semi Reclimet Tablet (10) with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826